ArticleNature communications2024

Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1.

Wenfeng Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.